Publications
Detailed Information
The Relationship between the Methylenetetrahydrofolate Reductase Genotypes and the Methylation Status of the CpG Island Loci, LINE-1 and Alu in Prostate Adenocarcinoma : 전립선 선암종에서 Methylenetetrahydrofolate Reductase 유전자형에 따른 CpG 섬 좌, LINE-1 및 Alu의 메틸화 양상 분석
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jung-Ho | - |
dc.contributor.author | Cho, Nam-Yun | - |
dc.contributor.author | Kim, Baek-Hee | - |
dc.contributor.author | Kim, Wook Youn | - |
dc.contributor.author | Moon, Kyung Chul | - |
dc.contributor.author | Kang, Gyeong Hoon | - |
dc.contributor.author | Kim, Bo Sung | - |
dc.date.accessioned | 2012-06-01T08:10:14Z | - |
dc.date.available | 2012-06-01T08:10:14Z | - |
dc.date.issued | 2009-02 | - |
dc.identifier.citation | KOREAN JOURNAL OF PATHOLOGY; Vol.43 1; 26-35 | ko_KR |
dc.identifier.issn | 1738-1843 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76727 | - |
dc.description.abstract | Background : Genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR), in association with the influence of MTHFR upon DNA methylation, may cause differences of the methylation profile of cancer. Thus, we investigated the relationship between the methylation status of prostate adenocarcinoma and the genetic polymorphism of MTHFR. Methods : We examined 179 cases of prostate adenocarcinoma for determining the genotypes of MTHFR 677 and 1298, the methylation status of 16 CpG island loci and the methylation levels of the LINE-1 and Alu repeats with using polymerase chain reaction/restriction fragment length polymorphism, methylation-specific polymerase chain reaction and combined bisulphite restriction analysis, respectively. Results : There was a higher proportion of the CT genotype of MTHFR 677 in the prostate adenocarcinoma than that in the normal control. The TT genotype of MTHFR 677 showed the highest frequency of methylation in six out of nine major CpG island loci, and these were which were frequently hypermethylated in prostate adenocarcinoma. The CT type showed the lowest methylation levels of LINE-1 and Alu among the MTHFR 677 genotypes. Interestingly, the CC type of MTHFR 1298 demonstrated favorable prognostic factors. Conclusions : Our study is the first to examine the methylation profile of prostate adenocarcinoma according to the MTHFR genotypes. The differences of the cancer risk, the genomic hypomethylation and the prognosis between the MTHFR genotypes in prostate adenocarcinoma should be further explored. | ko_KR |
dc.language.iso | ko | ko_KR |
dc.publisher | KOREAN SOCIETY PATHOLOGISTS | ko_KR |
dc.subject | Methylenetetrahydrofolate reductase | ko_KR |
dc.subject | Adenocarcinoma | ko_KR |
dc.subject | CpG islands | ko_KR |
dc.subject | DNA methylation | ko_KR |
dc.subject | Prostate | ko_KR |
dc.title | The Relationship between the Methylenetetrahydrofolate Reductase Genotypes and the Methylation Status of the CpG Island Loci, LINE-1 and Alu in Prostate Adenocarcinoma | ko_KR |
dc.title.alternative | 전립선 선암종에서 Methylenetetrahydrofolate Reductase 유전자형에 따른 CpG 섬 좌, LINE-1 및 Alu의 메틸화 양상 분석 | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김정호 | - |
dc.contributor.AlternativeAuthor | 조남윤 | - |
dc.contributor.AlternativeAuthor | 김백희 | - |
dc.contributor.AlternativeAuthor | 김욱연 | - |
dc.contributor.AlternativeAuthor | 김보성 | - |
dc.contributor.AlternativeAuthor | 문경철 | - |
dc.contributor.AlternativeAuthor | 강경훈 | - |
dc.identifier.doi | 10.4132/KoreanJPathol.2009.43.1.26 | - |
dc.citation.journaltitle | KOREAN JOURNAL OF PATHOLOGY | - |
dc.description.citedreference | Johansson M, 2007, CANCER CAUSE CONTROL, V18, P1169, DOI 10.1007/s10552-007-9055-z | - |
dc.description.citedreference | Hubner RA, 2007, INT J CANCER, V120, P1027, DOI 10.1002/ijc.22440 | - |
dc.description.citedreference | Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106 | - |
dc.description.citedreference | Pereira TV, 2006, CANCER EPIDEM BIOMAR, V15, P1956, DOI 10.1158/1055-9965.EPI-06-0334 | - |
dc.description.citedreference | Larsson SC, 2006, GASTROENTEROLOGY, V131, P1271, DOI 10.1053/j.gastro.2006.08.010 | - |
dc.description.citedreference | Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547 | - |
dc.description.citedreference | Graziano F, 2006, INT J CANCER, V118, P628, DOI 10.1002/ijc.21397 | - |
dc.description.citedreference | Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472 | - |
dc.description.citedreference | Kono S, 2005, CANCER SCI, V96, P535, DOI 10.1111/j.1349-7006.2005.00090.x | - |
dc.description.citedreference | Le Marchand L, 2005, CANCER EPIDEM BIOMAR, V14, P1198 | - |
dc.description.citedreference | Friso S, 2005, CURR DRUG METAB, V6, P37 | - |
dc.description.citedreference | Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987 | - |
dc.description.citedreference | Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137 | - |
dc.description.citedreference | Cicek MS, 2004, CANCER EPIDEM BIOMAR, V13, P1331 | - |
dc.description.citedreference | Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244 | - |
dc.description.citedreference | Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511 | - |
dc.description.citedreference | Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032 | - |
dc.description.citedreference | Nelson WG, 2003, NEW ENGL J MED, V349, P366 | - |
dc.description.citedreference | Gaudet F, 2003, SCIENCE, V300, P489 | - |
dc.description.citedreference | Bariol C, 2003, AM J PATHOL, V162, P1361 | - |
dc.description.citedreference | Shen HB, 2001, INT J CANCER, V95, P332, DOI 10.1002/1097-0215(20010920)95:5<332::AID-IJC1058>3.0.CO | - |
dc.description.citedreference | 2-9 | - |
dc.description.citedreference | Kimura F, 2000, PROSTATE, V45, P225 | - |
dc.description.citedreference | Weisberg I, 1998, MOL GENET METAB, V64, P169 | - |
dc.description.citedreference | Esteller M, 1997, CARCINOGENESIS, V18, P2307 | - |
dc.description.citedreference | Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290 | - |
dc.description.citedreference | Ma J, 1997, CANCER RES, V57, P1098 | - |
dc.description.citedreference | Chen J, 1996, CANCER RES, V56, P4862 | - |
dc.description.citedreference | FROSST P, 1995, NAT GENET, V10, P111 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.